KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Short-term Investments (2016 - 2025)

Sarepta Therapeutics (SRPT) has 14 years of Short-term Investments data on record, last reported at $237.9 million in Q3 2025.

  • For Q3 2025, Short-term Investments changed N/A year-over-year to $237.9 million; the TTM value through Sep 2025 reached $237.9 million, changed N/A, while the annual FY2024 figure was $251.8 million, 79.82% down from the prior year.
  • Short-term Investments reached $237.9 million in Q3 2025 per SRPT's latest filing, down from $289.5 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.2 billion in Q4 2023 and bottomed at $30.0 million in Q2 2021.
  • Average Short-term Investments over 5 years is $733.8 million, with a median of $986.1 million recorded in 2023.
  • Peak YoY movement for Short-term Investments: tumbled 92.88% in 2021, then soared 3431.51% in 2022.
  • A 5-year view of Short-term Investments shows it stood at $30.0 million in 2021, then skyrocketed by 3308.66% to $1.0 billion in 2022, then rose by 22.02% to $1.2 billion in 2023, then tumbled by 79.82% to $251.8 million in 2024, then decreased by 5.51% to $237.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $237.9 million in Q3 2025, $289.5 million in Q2 2025, and $281.9 million in Q1 2025.